120
Participants
Start Date
November 12, 2015
Primary Completion Date
October 29, 2024
Study Completion Date
October 29, 2024
PEGylated Recombinant Factor VIII
Polyethylene glycol (PEG)-ylated full-length recombinant FVIII (rFVIII).
ITI
Immune tolerance induction therapy
HUDERF, Brussels
Belgyogyaszat Onkohaematologia, Budapest
Medizinische Universitat Wien, Vienna
Acibadem Adana Hospital, Adana
Cliniques Uni Saint-Luc, Brussels
SHAT Oncohaematology Diseases, Sofia
Rigshospitalet Copenhagen, Copenhagen
Universitair Ziekenhuis Leuven, Leuven
UMHAT Sv. Georgi, EAD, Plovdiv
Debreceni Egyetem, Debrece
Akdeniz Universitesi, Antalya
Univ. Ziekenhuis Gent Apotheek, Ghent
MHAT Sv. Marina, EAD, Varna
New York Presbyterian Hospital, New York
King Chulalongkorn Memorial, Patumwan
Ramathibodi Hospital, Ratchathewi
Siriraj Hospital, Bangkoknoi
Hospital Pulau Pinang, George Town
Tri-Service General Hospital, Taipei
CHU CAEN Hopital Cote de Nacre, Caen
HOSPITAL A Coruna, A Coruña
Uludag Universitesi Tip Fakültesi, Bursa
MI Cherkasy Reg Onc Dis of CRC, Cherkasy
Ospedale Maggiore Policlinico, Milan
Poliklinik PaediaHaematologie, Hamburg
Hospital Sultanah Nur Zahirah, Terengganu
Wake Forest Baptist Medical Center, Winston-Salem
Hospital Universitario La Paz, Madrid
Novant Health Presbyterian Medical Center, Charlotte
Werlhof-Institut GmbH, Hanover
Center for Advanced Pediatrics, Atlanta
Hospital HRPB, Ipoh
Istanbul Üniversitesi Cerrahpaşa, Istanbul
Essais cliniques CHU Rennes, Rennes
Ege Universitesi Tip Fakultesi, Izmir
Eulji University Hospital, Daejeon
Erciyes Univers Tip Fakultesi, Kayseri
Srinagarind Hospital, Muang
Klinik F.Haematologie,Onkologie, Düsseldorf
China Medical University Hospital, Taichung
Taichung Veterans General, Taichung
Ulsan University Hospital, Ulsan
Rainbow Babies/Childrens Htl, Cleveland
Hospital Univ del Rio Hortega, Valladolid
Azienda Ospedaliera Universitaria Careggi, Florence
Maharaj Nakorn Chiang Mai, Muang
Hospital Kuala Lumpur, Kuala Lumpur
Inst. f. Experimentelle, Bonn
19 Mayis Universitesi, Samsun
Hopital Jeanne de Flandre - CHU Lille, Lille
Bleeding and Clotting Dis.Inst., Peoria
Hospital Ampang, Ampang
CI Zaporizhzhia Reg CCH of ZRC, Zaporizhzhia
Hopital Necker Enfants Malades, Paris
CHU de Rouen, Rouen
Texas Children's Hospital, Houston
SI Institute of Blood Pathology and Transfusion Medicine of NAMSU, Lviv
Texas Tech University Health Sciences Center, El Paso
Kaohsiung Chung- Ho Memorial Hosp, Kaohsiung City
Primary Children's Hospital, Salt Lake City
Phoenix Childrens Hospital, Phoenix
Hospital Umum Sarawak, Kuching
Kaiser Permanente Oakland M.C., Oakland
Kaiser Permanente Oakland M.C., Cupertino
Presidio Ospedaliero F. Alessi, Catania
Kaiser Permanente Oakland M.C., Roseville
UC Davis Health System, Sacramento
NUS YLL School of Medicine, Singapore
KKH, Singapore
Connecticut Children's Med Ctr, Hartford
Univ Florida College Medicine, Gainesville
Penn State MS Hershey Med Ctr, Hershey
Ann & Robert H. Lurie Children's H, Chicago
UMHS, Ann Arbor
Cincinnati Children's Hospital, Cincinnati
Kaye Edmonton Clinic, Edmonton
McMaster Health Science, Hamilton
Helsinki Univ Hospital, Helsinki
The University of Hong Kong Queen Mary Hospital, Hong Kong
Chinese University Of Hong Kong, Shatin
Umberto I Pol. di Roma-Università di Roma La Sapienza, Rome
Universitair Medisch Centrum Groningen (UMCG), Groningen
Oslo Universitetssykehus - Rikshospitalet, Oslo
Severance Hospital, Yonsei, Seoul
Kyung Hee University Hospital, Seoul
Hospital Univ. Son Espases, Palma de Mallorca
Hacettepe Üniversitesi, Ankara
Royal Manchester Children's Hospital, Manchester
Univ Hospital Southampton, Southampton
Bristol Royal H. for Children, Bristol
Evelina Children's Hospital - St Thomas' Hospital, London
Takeda Development Center Americas, Inc.
INDUSTRY
Baxalta now part of Shire
INDUSTRY